secwatch.observer — SEC 8-K summary
======================================

Issuer:     MASIMO CORP (MASI)
CIK:        0000937556
Form:       8-K
Filed at:   2025-01-16T23:59:59+00:00
Accession:  0000937556-25-000003
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Masimo reports preliminary Q4 2024 revenue ~$601M, healthcare up 9%; issues FY 2025 guidance
--------------------------------------------------------------------------------

- Q4 2024 consolidated revenue ~$601M (+9% YoY); healthcare revenue ~$368M (+8% reported, +9% constant currency).
- FY 2024 consolidated revenue ~$2,094M (+2%); healthcare $1,395M (+9%); non-healthcare $699M (-10%).
- Non-GAAP EPS FY 2024 expected >$4.10 (high end of prior guidance range).
- FY 2025 healthcare revenue guidance $1,500M-$1,530M (8-11% constant currency growth); non-GAAP EPS $4.90-$5.10.
- Q4 shipments of noninvasive technology boards/instruments ~65K units.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/937556/000093755625000003/0000937556-25-000003-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/937556/000093755625000003/masi-20250116.htm
  HTML page:      https://secwatch.observer/filing/0000937556-25-000003

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer